Cargando…
Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels
Clinical trials have demonstrated the safety and efficacy of autologous endothelial progenitor cell (EPC) therapy in various diseases. Since EPCs’ functions are influenced by genetic, systemic and environmental factors, the therapeutic potential of each individual EPCs is unknown and may affect trea...
Autores principales: | Sabbah, Nadin, Tamari, Tal, Elimelech, Rina, Doppelt, Ofri, Rudich, Utai, Zigdon-Giladi, Hadar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921061/ https://www.ncbi.nlm.nih.gov/pubmed/31717420 http://dx.doi.org/10.3390/biom9110717 |
Ejemplares similares
-
Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy
por: Tamari, Tal, et al.
Publicado: (2019) -
The Paracrine Role of Endothelial Cells in Bone Formation via CXCR4/SDF-1 Pathway
por: Tamari, Tal, et al.
Publicado: (2020) -
Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling
por: Doppelt-Flikshtain, Ofri, et al.
Publicado: (2023) -
Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect
por: Berg, Tal, et al.
Publicado: (2023) -
IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone
por: Kalkar, Prajakta, et al.
Publicado: (2022)